MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/1878-0261.70187

Медицинская библиотека · Molecular oncology · 2025

Therapeutic strategies for MMAE-resistant bladder cancer through DPP4 inhibition.

Li Gang, Tatarano Shuichi, Yoshino Hirofumi, Saito Saeki, Tominaga Mitsuhiko, Arima Junya, Fukuda Ikumi, Sakaguchi Takashi, Matsushita Ryosuke, Yamada Yasutoshi, Enokida Hideki

СтатьяПеревод в очереди

Аннотация

Monomethyl auristatin E (MMAE) is used as the cytotoxic payload for enfortumab vedotin (EV) in the treatment of locally advanced and metastatic bladder cancer (BC). However, the development of resistance to MMAE in BC is a therapeutic problem. To explore the mechanism of resistance to MMAE in BC, we established MMAE-resistant BC cells (MR-BCs). RNA sequencing analysis showed that the expression of dipeptidyl peptidase 4 (DPP4, also called CD26) increased significantly in MR-BCs compared with parental BC cells. Knock down of DPP4 expression using small interfering RNA inhibited the viability of MR-BCs. In addition, the DPP4 inhibitor sitagliptin suppressed the proliferation, migration, and invasion of BC cells, and cotreatment with MMAE effectively induced cell apoptosis, arrested cells in the G2M phase of the cell cycle, increased reactive oxygen species production by inhibiting the AKT pathway, and significantly inhibited the in vivo growth of MMAE-resistant cells. This study provides insights into the use of DPP4 inhibitors as a treatment strategy for MMAE-resistant BC.

Для цитирования: Li Gang, Tatarano Shuichi, Yoshino Hirofumi, Saito Saeki, Tominaga Mitsuhiko, Arima Junya, Fukuda Ikumi, Sakaguchi Takashi, Matsushita Ryosuke, Yamada Yasutoshi, Enokida Hideki. Therapeutic strategies for MMAE-resistant bladder cancer through DPP4 inhibition.. Molecular oncology. 2025. DOI: 10.1002/1878-0261.70187.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.